Stock RGLS REGULUS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq
Other stock markets
 01:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
2.27 USD +1.79% Intraday chart for Regulus Therapeutics Inc. -1.30% +77.34%
06/05 Regulus Therapeutics Advances to Cohort 4 of Phase 1B Multiple-Ascending Dose Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease CI
21/03 Regulus Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REGULUS THERAPEUTICS INC. Stock Regulus Therapeutics Inc.
 146M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 106B
ARGENX SE Stock argenx SE
 23.47B -
BIONTECH SE Stock BioNTech SE
 21.9B -
GENMAB A/S Stock Genmab A/S
 18.77B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 17.85B
  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Charts Regulus Therapeutics Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW